Inozyme Pharma Reports Positive Topline Data from Ongoing Ph

16.02.2023 - - Rapid, significant, and sustained increase in plasma pyrophosphate (PPi) observed and encouraging patient reported outcome data in all dose cohorts in ENPP1 Deficiency trial - - Rapid and significant increase in PPi observed in all dose cohorts ...

Related Keywords

United States , Boston , Massachusetts , Philadelphia , Pennsylvania , America , Inozyme Pharma , Matt Pera , Michaela Levine , Kurt Gunter , Axel Bolte , Mark Kiel , Wilko Spiering , Stefan Riley , Michael Levine , Division Of Internal Medicine , University Medical Center Utrecht Of , Linkedin , Twitter , Inozyme Pharma Inc , Division Of Endocrinology , Bone Health , Department Of Vascular Medicine , Nasdaq , Exchange Commission , Children Hospital Of Philadelphia Research Institute , International Number , Corporate Communications , Facebook , Professor Emeritus , Chief Emeritus , Philadelphia Research , Drug Antibody , Analyst Event , Conference Call , Philadelphia Research Institute , Associate Professor , Internal Medicine , Vascular Medicine , University Medical Center , Utrecht University , Chief Science Officer , Dial In Number , North America , Private Securities Litigation Reform Act , Annual Report , Quarterly Report ,